News

On the 24th September 2020 the Clinical Senate deliberated the question: “What should be the future Test and Trace Strategy for COVID 19 in the SW and how can we influence it?” Presentations Maggie Rae, Public Health England (National Initiatives and System Perspective) Debbie Stark, Public Health England (Regional Position & Data) Bruce Laurence, DPH,…

On the 16th July 2020 the Clinical Senate deliberated the questions: What beneficial innovations/changes have occurred in specialty and patient pathways as a result of the response to COVID 19? What has been the impact of these innovations/changes, what is needed to sustain them and what hasn’t worked so well? Download the recommendations here Agenda…

At the request of the South West and Peninsula Cancer Alliances, the South West Clinical Senate coordinated a discussion between clinicians from the cancer alliances and the senate, supported by expert input from Infection Prevention Control Leads and colleagues from Public Health England to agree a pathway for the delivery of immunosuppressant chemotherapy. Read the…

At the request of South West Regional Medical and Nursing Directors from NHS England and Improvement on 18th May, the South West Clinical Senate reviewed the recently published national guidance for hospitals to maintain provision for patients with COVID-19, whilst resuming other clinical services. The review meeting took place on 21st May 2020 and the…

On the 30th January 2020 the Clinical Senate reviewed selected past Council Meetings and outcomes of their Recommendations: Presentations Sally Pearson January 30th 2020 Dr Sally Pearson, Chair, South West Clinical Senate Biosimilar Medicines Recommendations Stephen Brown FFRPS FRPharmS, Regional Chief Pharmacist NHS England / NHS Improvement, South West and South East England Urgent Treatment…